Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/20247:12AMPR Newswire (US)Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
04/24/20247:11AMGlobeNewswire Inc.Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings PLC
04/24/20247:11AMBusiness WireHorizon FCB Dubaï dessine l'avenir de la publicité dans le secteur logistique avec la campagne « Delivered Yesterday » de DHL
04/24/20247:11AMBusiness WireHorizon FCB Dubai Charts the Future of Advertising in Logistics with DHL’s “Delivered Yesterday” Campaign
04/24/20247:10AMPR Newswire (US)QSAN Unveils Latest Solutions for AI Era at COMPUTEX 2024
04/24/20247:08AMAlliance NewsAlliance NewsApax Global Alpha invests EUR8 million in cybersecurity platformLSE:APAXApax Global Alpha Limited
04/24/20247:08AMPR Newswire (US)BINGHATTI LAUNCHES ITS DEBUT PROJECT ADJACENT TO DUBAI HILLS
04/24/20247:08AMGlobeNewswire Inc.Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
04/24/20247:06AMAlliance NewsAlliance NewsTOP NEWS: AT&T profit down but confident as hails "record-low" churnLSE:0QZ1At&t Inc.
04/24/20247:05AMAlliance NewsAlliance NewsConcurrent awarded USD1.8 million contract from US defence companyLSE:CNCConcurrent Technologies Plc
04/24/20247:05AMPR Newswire (Canada)METRO Inc. to launch Moi Rewards in Ontario offering new ways to save
04/24/20247:05AMGlobeNewswire Inc.Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyCSL.AX
04/24/20247:05AMPR Newswire (US)Silicon Labs Reports First Quarter 2024 ResultsNASDAQ:SLABSilicon Labs
04/24/20247:05AMPR Newswire (Canada)METRO inc. lance Moi en Ontario offrant de nouvelles façons d'économiser
04/24/20247:05AMGlobeNewswire Inc.Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA NephropathyNASDAQ:TVTXTravere Therapeutics Inc
04/24/20247:05AMPR Newswire (US)REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:RGNXREGENXBIO Inc
04/24/20247:04AMAlliance NewsAlliance NewsHeathrow ups passenger growth outlook after record start to 2024
04/24/20247:04AMPR Newswire (US)QSAN Unveils Latest Solutions for AI Era at COMPUTEX 2024
04/24/20247:03AMPR Newswire (US)Coast survey finds construction companies have significant gaps in their field expense management practices
04/24/20247:03AMPR Newswire (US)Too Much Acid in Your Diet: It's Probably Your Coffee
04/24/20247:03AMPR Newswire (US)Taylor Morrison Opens One of The Final New Build Communities in the Arvada MarketNYSE:TMHCTaylor Morrison Home Holding Company
04/24/20247:02AMAlliance NewsAlliance NewsEXTRA: Warpaint boosts annual earnings as consumers stick by cosmeticsLSE:W7LWarpaint London Plc
04/24/20247:01AMPR Newswire (US)Travelzoo Reports First Quarter 2024 ResultsNASDAQ:TZOOTravelzoo
04/24/20247:01AMGlobeNewswire Inc.HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated CancersNASDAQ:HOOKHOOKIPA Pharma Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-B
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsNYSE:RCIRogers Communications Inc
04/24/20247:00AMGlobeNewswire Inc.Rogers Communications Reports First Quarter 2024 ResultsRCI-A
04/24/20247:00AMGlobeNewswire Inc.Shenandoah Telecommunications Company to Hold its First Quarter 2024 Earnings Call at 8:30 a.m. on Friday, May 3, 2024NASDAQ:SHENShenandoah Telecommunications Company
04/24/20247:00AMGlobeNewswire Inc.Smart Share Global Limited Files Its Annual Report on Form 20-FNASDAQ:EMSmart Share Global Limited
04/24/20247:00AMGlobeNewswire Inc.atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant DepressionNASDAQ:ATAIATAI Life Sciences NV